Schedule 13D ownership disclosure
ACURA PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 00509L802
Event date: 2017-07-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,695,186
- Percent of class
- 47.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-040198
- Form type
- SC 13D
- Filer
- ACURA PHARMACEUTICALS, INC
- CIK
- CIK 786947
- Filed
- Aug 03, 2017
- Reporting period
- Jul 24, 2017
- Description
- Schedule 13D beneficial ownership